Login to Your Account



BARDA adds MDCO, Roche as antimicrobial portfolio partners

By Marie Powers
News Editor

Wednesday, September 21, 2016

The Medicines Co. and Roche AG unit Hoffmann-Laroche Inc. are joining the effort launched by BARDA to develop products to combat the emerging threat of multidrug-resistant bacterial infections, superbugs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription